ADVB: Pangali rega marang bathi tumrap wutah Advanced Biomed Inc
The reduction of regulatory risks through US patenting is driving the momentum reflected in the PEG ratio for Advanced Biomed Inc (ADVB), with 0.00 representing the metric's latest reading. Growth in wholesale sales and insurance codes support the business, while microfluidic systems enable ultra-precise detection of tumor cells. This chart helps identify areas where the asset is undervalued relative to profit growth rates.
Rincian analitis perusahaan Advanced Biomed Inc (ADVB)
- rega saham lan konsensus proyeksi valuasi:
- informasi kapitalisasi pasar:
- indikator nilai buku ekuitas:
- rincian struktur utang lan likuiditas bisnis:
Utang marang Modal Advanced Biomed Inc|ADVB - Utang jangka dawa marang modal|Utang jangka cendhak marang modal advanbiomed.com|ADVB - Gunggung utang perusahaan|Rasio utang marang nilai buku Advanced Biomed Corp|ADVB - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Advanced Biomed|Rasio cepet advanbiomed.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
ADVB - Bathi resik perusahaan|Prakiraan bathi resik Advanced Biomed Inc|ADVB - Pangali P/E|Prakiraan rega marang bathi advanbiomed.com|ADVB - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Advanced Biomed Corp|ADVB - Bathi operasional EBITDA|Bathi saben saham sajrone 12 wulan pungkasan Advanced Biomed|ADVB - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan advanbiomed.com|ADVB - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Advanced Biomed Inc
Analisis umum perusahaan:Advanced Biomed Inc. (ADVB)
Advanced Biomed Inc (ADVB) invests in high-tech R&D to develop early cancer diagnostic systems. The PEG ratio compares the current P/E multiple with earnings growth to determine the asset's fair value. A decline of the line below one on the chart signals that the company is undervalued relative to its expansion. This metric allows analysts to filter out speculative noise when evaluating capitalization. It is critical for investors to consider the risk of cross-market decorrelation when making decisions.
Karo sapa Advanced Biomed Inc saingan
ONC (BeiGene Ltd.) - Koefisien bali modal nimbang wutah|Pangali PEG HALO (Halozyme Inc.)|RVMD - Pangali rega marang bathi tumrap wutah|AAPG: Pangali rega marang bathi tumrap wutah|CGON - Pangali PEG|UroGen Pharma (URGN) - Rasio rega marang bathi tumrap wutah|Bicara Therapeutics Inc - Koefisien bali modal nimbang wutah|PSNL (Personalis Corp) - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Erasca Oncology ERAS|Pangali PEG DCTH|Pangali PEG ymabs.com (YMAB)|Pangali PEG AURA (Aura Biosciences)|CADL: Rasio P/E diaturake wutah|ARAY: Pangali rega marang bathi tumrap wutah|SLS: Rasio rega marang bathi tumrap wutah|ACTU: Pangali PEG|citiusonc.com (CTOR) - Pangali PEG|Rasio rega marang bathi tumrap wutah TuHURA Biosciences Inc.|Rasio P/E diaturake wutah TARA (Protara Therapeutics Inc)|Pangali PEG FATE|Pangali rega marang bathi tumrap wutah aadibio.com WHWK|Pangali PEG TCRX (TScan Therapeutics, Inc.)|Champions Oncology Inc (CSBR) - Rega marang bathi kanthi panyesuaian wutah|XBiotech USA - Pangali PEG|CVM (CEL-SCI Corporation) - Rasio P/E diaturake wutah|OSTX (OS Therapies Inc) - Pangali rega marang bathi tumrap wutah|Radiopharm Theranostics Ltd - Koefisien bali modal nimbang wutah|ARTV (Artiva Biotherapeutics Inc.) - Pangali PEG|Rasio rega marang bathi tumrap wutah ANL|Pangali PEG VERU|Kapitalisasi marang bathi resik kanthi nimbang wutah Tempest Therapeutics Inc|Rasio rega marang bathi tumrap wutah Xilio Therapeutics XLO|Renovaro Biosciences (RENB) - Rega marang bathi kanthi panyesuaian wutah|MURA - Rasio rega marang bathi tumrap wutah|Kairos Pharma Ltd (KAPA) - Pangali rega marang bathi tumrap wutah|OKUR: Pangali PEG|Rega marang bathi kanthi panyesuaian wutah CytoMed Therapeutics Limited (GDTC)|CRIS (Curis Inc.) - Pangali PEG|Rasio P/E diaturake wutah APLM (Apollomics Corp)|Pangali rega marang bathi tumrap wutah THAR (Tharimmune, Inc.)|GNPX (genprex.com) - Koefisien bali modal nimbang wutah|Pangali PEG CLDI (Calidi Biotherapeutics, Inc.)|Kapitalisasi marang bathi resik kanthi nimbang wutah Sunshine Biopharma Inc. (SBFM)|XBIO - Rasio rega marang bathi tumrap wutah|SLRX (Salarius Pharma) - Rasio P/E diaturake wutah|PPBT: Pangali PEG|Pangali rega marang bathi tumrap wutah American Oncology Network, Inc.|BGNE (BeiGene) - Pangali PEG|Pangali PEG Checkpoint Therapeutics Inc.|Pangali PEG ELEV|icadmed.com - Rasio P/E diaturake wutah|Ikena Oncology - Pangali rega marang bathi tumrap wutah|notablelabs.com - Rasio rega marang bathi tumrap wutah|Viracta - Pangali PEG|MOR: Rasio rega marang bathi tumrap wutah|NAYA: Pangali PEG|Pangali rega marang bathi tumrap wutah Ascentage
